Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



From the category archives: OBN News

Product & Service Announcements

AMSBIO has announced a new range of CD47-relevant products suitable for rapid high throughput screening studies.

 The new AMSBIO CD47 protein kits are supplied as pairs of products that can be easily adapted to ELISA, AlphaLISA™ and MSD platforms to facilitate rapid and easy screening of the neutralizing compound.

Read the rest of entry »

Wireless technology breathes new life into medical practices

A leading clinician of a top UK children’s hospital believes wireless monitoring is changing the face of healthcare.

Read the rest of entry »

Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures

Merck Ventures Joins Investment Syndicate and the Board of Macrophage

Read the rest of entry »

Oxford Immunotec Global PLC Announces Agreement to Sell 2,500,000 Ordinary Shares

Oxford Immunotec intends to use the net proceeds from the offering for working capital and general corporate purposes.

Read the rest of entry »

China- Visit by the Future Health Industry Entrepreneurs Association

The Department for International Trade Life Sciences Organisation (DIT LSO) and the China Britain Business Council (CBBC) will be hosting a delegation from the Future Health Industry Entrepreneurs Association (FHA) from China on the morning of Tue 5 Sep.

Read the rest of entry »

ELISA-like Assay for Hyaluronic Acid

AMSBIO announces the launch of a new Hyaluronic Acid Quantification Kit, based on a highly specific and tightly binding protein to detect and measure Hyaluronic Acid, also known as Hyaluronan or HA.

 

Read the rest of entry »

Wickham Laboratories Article on Working with Difficult Preparations Published by IPI

Wickham Laboratories is pleased to announce that an article written by our CEO, John McKenzie, has recently been published by International Pharmaceutical Industry (IPI).

Read the rest of entry »

Devising an efficient roadmap for early stage & start-up companies to maximise value & chances of success

OBN BioTuesday Pennington Manches

Read the rest of entry »

Wickham Laboratories Now Offering Full Suite of Medical Device Biocompatibility and Safety Testing

Medical device testing is one of the most complex services offered in the life sciences sector, both for the diversity of the product tested and for the different level of safety or biocompatibility required prior to approval for use in patients.

Read the rest of entry »

Immunocore announces third oncology target selected in discovery collaboration with GlaxoSmithKline

Immunocore will generate a novel ImmTAC® molecule against the selected target which is relevant in multiple cancers.

Read the rest of entry »

Pages: Previous123456NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.